Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma. Various factors play a role in whether or not a patient is ...

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma. The Food and Drug Administration (FDA) has approved ...

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this ...

Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibody Use in Earlier Lines of Treatment of Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma Treatment of multiple myeloma ...

A single-drug approach for newly diagnosed multiple myeloma may simplify treatment while maintaining efficacy, improving patient quality of life. Suleika Jaouad's leukemia experience highlights the ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Bortezomib for Injection in the United States. The product contains ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer ...

MIAMI, FLORIDA (Feb. 15, 2024) – Prominent oncologist and researcher Damian Green, M.D., will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring ...

Daratumumab and hyaluronidase (Darzalex Faspro, Johnson & Johnson) came a step closer to being approved for high-risk smoldering multiple myeloma (SMM) on Tuesday after the Oncologic Drugs Advisory ...

Bryon Daily did not fit the profile of someone at risk for a rare blood condition. After all, he said he was under 60, physically fit, and had no family history of the disease. But after a seemingly ...